Bonraybio Co., Ltd.
Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also offers consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes. In addition, the company provides X… Read more
Market Cap & Net Worth: Bonraybio Co., Ltd. (6955)
Bonraybio Co., Ltd. (TW:6955) has a market capitalization of $129.68 Million (NT$4.29 Billion) as of March 18, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #20756 globally and #1101 in its home market, demonstrating a 0.58% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bonraybio Co., Ltd.'s stock price NT$173.00 by its total outstanding shares 24801000 (24.80 Million).
Bonraybio Co., Ltd. Market Cap History: 2025 to 2026
Bonraybio Co., Ltd.'s market capitalization history from 2025 to 2026. Data shows growth from $110.94 Million to $129.68 Million (0.00% CAGR).
Bonraybio Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bonraybio Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6955 by Market Capitalization
Companies near Bonraybio Co., Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to Bonraybio Co., Ltd. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Bonraybio Co., Ltd. Historical Marketcap From 2025 to 2026
Between 2025 and today, Bonraybio Co., Ltd.'s market cap moved from $110.94 Million to $ 129.68 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$129.68 Million | +16.89% |
| 2025 | NT$110.94 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Bonraybio Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $129.68 Million USD |
| MoneyControl | $129.68 Million USD |
| MarketWatch | $129.68 Million USD |
| marketcap.company | $129.68 Million USD |
| Reuters | $129.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.